Unique ID issued by UMIN | UMIN000001530 |
---|---|
Receipt number | R000001847 |
Scientific Title | Phase II trial of capecitabine for brain metastasis of breast cancer |
Date of disclosure of the study information | 2008/12/01 |
Last modified on | 2011/03/07 21:07:16 |
Phase II trial of capecitabine for brain metastasis of breast cancer
Capecitabine-brain meta
Phase II trial of capecitabine for brain metastasis of breast cancer
Capecitabine-brain meta
Japan |
brain metastasis of breast cancer
Hematology and clinical oncology |
Malignancy
NO
Efficacy
Safety
Response rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Capecitabine
18 | years-old | <= |
Not applicable |
Male and Female
1)Patient with breast cancer
2)At least one brain metastasis by RECIST
3)Prior treated patient by systemic chemotherapy
The patient have not indication for capecitabine therapy
32
1st name | |
Middle name | |
Last name | Tsutomu Kouno |
National cancer center hospital
Breast and Medical Oncology
5-1-1 Tsukiji, Chuo-ku, Tokyo
1st name | |
Middle name | |
Last name | Masashi Ando |
National cancer center hospital
Breast and Medical Oncology
National cancer center hospital
None
Self funding
NO
2008 | Year | 12 | Month | 01 | Day |
Unpublished
Terminated
2006 | Year | 09 | Month | 25 | Day |
2007 | Year | 02 | Month | 01 | Day |
2011 | Year | 01 | Month | 01 | Day |
2008 | Year | 11 | Month | 26 | Day |
2011 | Year | 03 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001847